COMMUNIQUÉS West-GlobeNewswire

NEOVACS : Mise à disposition du rapport financier Annuel 2017

27/04/2018 - 18:01

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Mise à disposition du rapport financier Annuel 2017 Paris et Boston, le 27 avril 2018 - NEOVACS (Alternext Paris : ALNEV), leader de l'immunothérapie [...]

Solon Eiendom ASA : Primary insider notification

27/04/2018 - 17:30

(Oslo, Norway, April 27, 2018) Solon Eiendom ASA Board Member Runar Vatne has today transferred 4,000,000 shares in Solon Eiendom ASA from his indirectly wholly owned company Vatne Equity AS at a price of NOK 25.00 per [...]

Navamedic ASA: Annual Report 2017

27/04/2018 - 16:44

Attached: The Annual Report 2017 for Navamedic ASA. The report will also be available on Navamedic's web site: www.navamedic.com . For further information please contact: Toril Ås Chief Financial Officer E-mail: toril. [...]

JSC Olainfarm Concludes Year 2017 With The Highest Turnover Of The Company's History And Expands Globally

27/04/2018 - 16:24

April 27, 2018 JSC Olainfarm Concludes Year 2017 With The Highest Turnover Of The Company's History And Expands Globally Audited consolidated financial statement of JSC Olainfarm for 2017 shows that the sales of the [...]

Kannalife Sciences CEO Dean Petkanas to Provide Presentation on Industry Advancement at 2018 Cannabinoids in Medicine Summit

27/04/2018 - 16:00

NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a phyto-medical company, announced today that the Company’s CEO Dean Petkanas will be presenting at the 2018 Cannabinoids in Medicine [...]

Corporate Governance Report

27/04/2018 - 15:58

Corporate Governance Report AS Olainfarm hereby publishes its Corporate Governance Report for the reporting year of 2017 Information prepared by: Salvis Lapins JSC Olainfarm Member of the Management Board Rupnicu iela 5 [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mars 2018

27/04/2018 - 15:43

Communiqué de presse Villepinte, le 27 avril 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Teligent, Inc. Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023

27/04/2018 - 15:25

BUENA, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ) (“Teligent”) announced today that it has entered into separate, privately negotiated exchange agreements with certain holders of Teligent’s [...]

IntelGenx to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference

27/04/2018 - 15:15

SAINT LAURENT, Quebec, April 27, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) (the "Company" or "IntelGenx") today announced that its President and Chief Executive Officer, Dr. [...]

the Corporative Governance Report for 2017.

27/04/2018 - 15:06

Latvia, 2018-04-27 15:06 CEST (GLOBE NEWSWIRE) -- JSC "Latvijas Jūras medicīnas centrs” publish the Corporative Governance Report for 2017. Valdes loceklis Juris Imaks, tel. 29512492

Latvijas Juras medicinas centrs JSC. Audited reports for 2017.

27/04/2018 - 15:03

Latvia, 2018-04-27 15:03 CEST (GLOBE NEWSWIRE) -- Latvijas Juras medicinas centrs JSC: audited report for the Year 2017. Member of the Board: Juris Imaks, phone: 29512492

GENFIT: Publication of the 2017 Registration Document

27/04/2018 - 15:00

GENFIT: PUBLICATION OF THE 2017 REGISTRATION DOCUMENT Lille (France), Cambridge (Massachusetts, United States), April 27, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at the forefront [...]

GENFIT : Mise à disposition du Document de Référence 2017

27/04/2018 - 15:00

GENFIT : MISE A DISPOSITION DU DOCUMENT DE REFERENCE 2017 Lille (France), Cambridge (Massachusetts, Etats-Unis), le 27 avril 2018 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique engagée dans [...]

Chiesi Named Signature Sponsor of the Triangle March for Babies Walk & 5K Run

27/04/2018 - 15:00

The community is invited to walk and support March of Dimes efforts CARY, N.C., April 27, 2018 (GLOBE NEWSWIRE) -- Chiesi is proud to be named the signature sponsor of the 2018 Triangle March for Babies Walk & 5K [...]

Blink Charging Company Enters into Reseller Agreement with Tauriga Biz Dev. Corp. to Further Expand its Leading Electric Vehicle Charging Network

27/04/2018 - 15:00

NEW YORK, NY, April 27, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

27/04/2018 - 14:31

FIT Biotech Oy Company release April 27, 2018 at 3:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Hemostemix Announces Trial Site for Phase II Clinical Trial

27/04/2018 - 14:30

CALGARY, Alberta, April 27, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE:HEM) is pleased to announce that it has entered into an agreement and has received all approvals from [...]

Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated

27/04/2018 - 14:30

Execution of 2018 Transformation Plan is on Target RUTHERFORD, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular [...]

The Drug Committee of Ministry of Health, Labour and Welfare in Japan has accepted a 2-year extension of market exclusivity of Lexapro®

27/04/2018 - 14:29

A two-year extension of the reexamination period by the Japanese Ministry of Health, Labour and Welfare (MHLW) has been discussed and accepted in the First Committee on Drug of MHLW The acceptance is based on the fact [...]